Yuedi W. Fleming

Statistics

Publications

Citations

159

H-Index

Active since

2008

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Yuedi W. Fleming is an author at Bristol-Myers Squibb (Switzerland) specializing in hematologic malignancy pharmacotherapy, chemotherapy-induced apoptosis, and natural killer cell biology.

Publications per year

2008–2008

Publications

Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation

Dan Zhu, Laura G. Corral, Yuedi W. Fleming et al. · Cancer Immunology Immunotherapy · 2008 · 159 citations · Full text

Medicine, Oncology, Pharmacology +14

1–1 of 1